SUBSCRIBE
SUBSCRIBE

North Carolina

Pictured: Novo Nordisk's office in Fremont, California
Drug Development
Novo Nordisk Continues Manufacturing Spending Spree With $4.1B Investment
Novo Nordisk on Monday announced it is boosting its manufacturing capabilities with a $4.1 billion commitment to construct a second fill and finishing facility in Clayton, North Carolina.
June 25, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Fujifilm's head office in Canada
Job Trends
Fujifilm Pumps $1.2B into CDMO Capacity in North Carolina, Eyes 680 New Jobs by 2031
The global contract development and manufacturing organization is investing $1.2 billion to boost production capabilities at its Holly Springs, North Carolina, site including mammalian cell culture bioreactors.
April 12, 2024
 · 
2 min read
 · 
Tristan Manalac
Facade of the FDA's office in Maryland
Policy
FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates
The regulator placed the clinical hold on the Chinese biotech’s trio of CAR-T cell therapy candidates after an inspection of its Durham, North Carolina manufacturing facility.
December 15, 2023
 · 
2 min read
 · 
Tyler Patchen
Courtesy of Cristina Arias/Getty Images
Job Trends
New Lilly Manufacturing Plant to Bring 600 Jobs to North Carolina
Eli Lilly and Company announced plans to build a new manufacturing plant in Concord, North Carolina.
January 31, 2022
 · 
2 min read
 · 
Mark Terry
Load More
PRESS RELEASES
Press Releases
Javara Secures Series C Funding To Drive Therapeutic Expansion For Community-Forward Clinical Research
May 28, 2025
 · 
2 min read
Press Releases
TruTechnologies Secures Significant Growth Investment From LLR Partners
May 28, 2025
 · 
3 min read
Press Releases
BioCryst to Present at Upcoming June 2025 Investor Conferences
May 28, 2025
 · 
1 min read
Press Releases
SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection
May 27, 2025
 · 
6 min read
Press Releases
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders
May 27, 2025
 · 
11 min read
Press Releases
Bantam Pharmaceutical to Present at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
May 23, 2025
 · 
5 min read
Press Releases
Worldwide Clinical Trials Joins WCG’s Avoca Quality Consortium to Elevate Clinical Trial Quality
May 21, 2025
 · 
3 min read
Press Releases
Verona Pharma Announces June 2025 Investor Conference Participation
May 21, 2025
 · 
1 min read
Press Releases
Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis
May 20, 2025
 · 
3 min read
Press Releases
Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq
May 20, 2025
 · 
2 min read
Press Releases
Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference
May 19, 2025
 · 
1 min read
Press Releases
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
May 19, 2025
 · 
6 min read
Press Releases
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
May 19, 2025
 · 
5 min read
Press Releases
Synoligo Biotechnologies and Lumiphore Announce a Partnership to Provide [Time-Resolved] Luminescent Oligos and Assays for the Nucleic Acid Amplification Testing Market (NAAT)
May 19, 2025
 · 
2 min read
Press Releases
IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
May 16, 2025
 · 
4 min read
Press Releases
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)
May 16, 2025
 · 
7 min read
Press Releases
Xenon MRI Featured Prominently at ATS 2025 Across Broad Clinical Spectrum
May 16, 2025
 · 
11 min read
Press Releases
vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
May 15, 2025
 · 
7 min read
Press Releases
vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes
May 15, 2025
 · 
4 min read
Press Releases
Opus Genetics Announces Financial Results for First Quarter 2025 and Provides Corporate Update
May 15, 2025
 · 
19 min read
Load More